Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Sanofi is trumpeting new data for its anti-CD38 drug Sarclisa as it tries to capture market share from Johnson & Johnson’s blockbuster Darzalex in the multiple myeloma market. A couple of months ...

Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug UK is becoming an 'outlier' for pharma, hitting investment Sofinnova closes new fund and backs a trio of new biotechs ...